Bayer, Nektar in antibiotic agreement
Bayer HealthCare has joined forces with US firm Nektar Therapeutics to develop a new inhalable antibiotic for the treatment of acute pneumonias.
Archives for August 6, 2007
Covance, Nanostream, launch new discovery services
Contract research organisation (CRO) Covance and laboratory services firm Nanostream have both recently launched new drug discovery offerings.
QDose closes in on Exubera
An improved inhalable insulin product developed by collaborating UK and US firms has just completed a glucose clamp study in the US, with results suggesting that the product could pose a significant threat to Pfizer's Exubera franchise.
Celsis tech gets pharma recognition
Celsis' Rapid Microbiological Method (RMM) has been included in GlaxoSmithKline's (GSK) successful Veramyst New Drug Application (NDA), paving the way for broader acceptance of the time saving technique.
Outsourcing-Pharma.com special focus
Court sanctions independent trustee for Inyx USA
A US bankruptcy court judge ruled on Friday that Puerto Rican-based pharma services firm Inyx USA be put under the control of an independently-appointed trustee.
ChanTest to expand ion-channel screening
ChanTest has received private equity financing by Ampersand Ventures to enable the company to expand its library of ion channel-expressing cell lines for drug screening.
Alzheimer's hits glaucoma between the eyes
UK researchers have published results linking the beta amyloid protein associated with Alzheimer's disease to glaucoma, opening up a much needed new target for glaucoma therapies.